COOPER COMPANIES, INC.

COO 10-Q · Q1 2026

COO Q1 2026 request

Playground key active
Request URL /api/financials?ticker=COO&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 1,024.1 964.7 +6.2%
Show Product Lines breakouts
Fertility · Coopersurgical Segment 126.6 119.7 +5.8%
Office and surgical · Coopersurgical Segment 202.4 198.9 +1.8%
Sphere, other · Coopervision Segment 343.9 326.7 +5.3%
Toric and multifocal · Coopervision Segment 351.2 319.4 +10.0%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 329 318.6 +3.3%
Coopersurgical Segment · Operating Segments 329 318.6 +3.3%
CooperVision Segment · Operating Segments 695.1 646.1 +7.6%
Coopervision Segment · Operating Segments 695.1 646.1 +7.6%
Show Geography breakouts
Europe 326.4 287.5 +13.5%
Rest of world 183.8 180.8 +1.7%
US 513.9 496.4 +3.5%
Cost of Revenue 328.9 304.5 +8.0%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 108.1 99.5 +8.6%
CooperVision Segment · Operating Segments 220.8 205 +7.7%
Gross Profit 695.2 660.2 +5.3%
Selling, General & Administrative 390.2 387.9 +0.6%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 128.4 135.9 -5.5%
CooperVision Segment · Operating Segments 237.6 229.9 +3.3%
Show Consolidation Items breakouts
Corporate Non Segment 24.2 22.1 +9.5%
Research & Development 44.3 40.7 +8.8%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 21.9 18.2 +20.3%
CooperVision Segment · Operating Segments 22.4 22.5 -0.4%
Amortization Of Intangible Assets 47.9 49.6 -3.4%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 43.8 44.8 -2.2%
CooperVision Segment · Operating Segments 4.1 4.8 -14.6%
Operating Income 212.8 182 +16.9%
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 26.8 20.2 +32.7%
CooperVision Segment · Operating Segments 210.2 183.9 +14.3%
Show Consolidation Items breakouts
Corporate Non Segment -24.2 -22.1 -9.5%
Interest Expense 22.4 26 -13.8%
Other Non-Operating Income (Expense) -1.8 2.7 -166.7%
Income Before Taxes 192.2 153.3 +25.4%
Income Tax Expense (Benefit) 61.4 49 +25.3%
Net Income 130.8 104.3 +25.4%
Show Equity Components breakouts
Retained Earnings 130.8 104.3 +25.4%
EPS (Basic) 0.67 0.52 +28.8%
EPS (Diluted) 0.66 0.52 +26.9%
Wtd Avg Shares (Basic) 195.8 199.7 -2.0%
Wtd Avg Shares (Diluted) 196.7 201.2 -2.2%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax -4 -2 -100.0%
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 76.5 -66.7 +214.7%
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 203.3 35.6 +471.1%
Non-Operating Income (Expense) -1.8 2.7 -166.7%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax 0.7 6.9 -89.9%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 124.9 100.9 +23.8%
Accounts Receivable 807.1 716.4 +12.7%
Inventory 876.4 842.9 +4.0%
Prepaid Expenses & Other Current Assets 325.4 326.8 -0.4%
Total Current Assets 2,133.8 1,987 +7.4%
Non-Current Assets
Goodwill 3,905.4
Deferred Tax Assets 2,038.3 2,175.3 -6.3%
Other Non-Current Assets 688.4 663.7 +3.7%
Total Assets 12,424.2
Show Business Segments breakouts
CooperSurgical Segment · Operating Segments 4,584.6
CooperVision Segment · Operating Segments 7,655.7
Show Consolidation Items breakouts
Corporate Non Segment 183.9
Intangible Assets 1,540.5
Other Assets
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 2,116.7 1,864.7 +13.5%
Intangible Assets Net Excluding Goodwill 1,541.6
Current Liabilities
Debt Current 620.7 48.7 +1174.5%
Accounts Payable 225.8 201.5 +12.1%
Employee Related Liabilities Current 209.6 190.4 +10.1%
Deferred Revenue (Current) 129.9 126.3 +2.9%
Other Liabilities Current 409.7 432.7 -5.3%
Total Current Liabilities 1,595.7 999.6 +59.6%
Non-Current Liabilities
Deferred Tax Liabilities 96.3 95.2 +1.2%
Accrued Income Taxes Noncurrent 5.6 54.3 -89.7%
Contract With Customer Liability Noncurrent 206.4 193.4 +6.7%
Other Non-Current Liabilities 277.2 261 +6.2%
Total Liabilities 4,060.2 4,094.7 -0.8%
Long-Term Debt 1,877.3 2,489.1 -24.6%
Other Liabilities
Long Term Debt And Capital Lease Obligations 1,879 2,491.2 -24.6%
Stockholders' Equity
Common Stock 21.8 21.7 +0.5%
Additional Paid-In Capital 1,987.1 1,928.3 +3.0%
Accumulated Other Comprehensive Income -334 -490.4 +31.9%
Retained Earnings 7,774.1 7,372.7 +5.4%
Treasury Stock Common Value -1,085.2 -705 -53.9%
Total Stockholders' Equity 8,363.8 8,127.3 +2.9%
Minority Interest 0.2 0.2 0.0%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8,364 8,127.5 +2.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 1.7 -4.9 +134.7%
Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent 18.4 57.2 -67.8%
Accumulated Gain Loss Net Cash Flow Hedge Parent 14 42.9 -67.4%
Accumulated Other Comprehensive Income -334 -490.4 +31.9%
Accumulated Translation Adjustment -349.7 -528.4 +33.8%
Additional Paid In Capital 1,987.1 1,928.3 +3.0%
Common Shares 20 19.9 +0.5%
Noncontrolling Interest 0.2 0.2 0.0%
Retained Earnings 7,774.1 7,372.7 +5.4%
Treasury Stock 1.8 1.8 0.0%
Treasury Stock Common -1,085.2 -705 -53.9%
Total Liabilities & Equity 12,424.2 12,222.2 +1.7%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization 95.5 91 +4.9%
Business Combination Contingent Consideration Arrangements Settlement Amount Of Contingent Consideration Liability -0.5
Increase Decrease In Operating Capital -36.1 -75.6 +52.2%
Deferred Income Taxes 43.6 34.6 +26.0%
Other Non-Cash Items 27.6 36.3 -24.0%
Net Cash from Operations 260.9 190.6 +36.9%
Investing Activities
Capital Expenditures -102.2 -89.4 -14.3%
Payments To Acquire Businesses And Assets Net Of Cash Acquired And Other -0.7 -7.4 +90.5%
Net Cash from Investing -102.9 -96.8 -6.3%
Financing Activities
Proceeds From Issuance Of Long Term Debt 875.4 670.3 +30.6%
Repayments Of Long Term Debt -904.2 -729.5 -23.9%
Payments To Acquire Business Gross Installments -44.5 -47.1 +5.5%
Proceeds From Repayments Of Short Term Debt 22 16 +37.5%
Proceeds From Payments Of Share Based Arrangement -6.7 -8.5 +21.2%
Share Repurchases -92.5
Proceeds From Stock Plans 3.9 2.2 +77.3%
Payment For Contingent Consideration Liability Financing Activities -1.3
Net Cash from Financing -147.9 -96.6 -53.1%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 4.3 -3.9 +210.3%
Net Change in Cash 14.4 -6.7 +314.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 125 101 +23.8%
Restricted Cash And Cash Equivalents At Carrying Value 0.1 0.1 0.0%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key